Brief: Genextra S.p.A. Reports 5.89% Passive Stake In Quince Therapeutics As Of Oct 20
Dec 15 (Reuters) - Quince Therapeutics Inc QNCX.O :
* GENEXTRA S.P.A. REPORTS 5.89% PASSIVE STAKE IN QUINCE
THERAPEUTICS AS OF OCT 20 - SEC FILING
Source text for Eikon: [ID: https://www.sec.gov/Archives/edgar/data/1559515/000114036123057682/ef20016690_sc13g.htm
]
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges